濮阳东方医院妇科看病便宜吗濮阳东方医院男科割包皮手术很专业,濮阳东方男科医院网络预约,濮阳东方医院男科割包皮非常便宜,濮阳东方妇科口碑非常高,濮阳东方医院妇科上班时间,濮阳东方医院男科治疗早泄技术非常哇塞,濮阳东方医院妇科导航

LOS ANGELES (CNS) - Pop star Ariana Grande is suing fashion retailer Forever 21 and its spin-off cosmetics brand, Riley Rose, for million, alleging in court papers filed in Los Angeles that the company used a look-alike model in an ad campaign without permission.The complaint, filed in U.S. District Court, alleges that the trademark violations took place in late 2018 and early this year, using unlicensed imagery from her ``Thank U, Next'' album and ``7 Rings'' music video.A Forever 21 representative issued a statement on the company's behalf.``While we dispute the allegations, we are huge supporters of Ariana Grande and have worked with her licensing company over the past two years,'' the statement reads. ``We are hopeful that we will find a mutually agreeable resolution and can continue to work together in the future.''Grande alleges that Forever 21 ran the ad campaign on its website and social media platforms.``As of February 2019, Ms. Grande became the most-followed woman on Instagram in the world, amassing more than 160 million Instagram followers; a title she continues to hold through the date of filing this complaint," according to the lawsuit. ``Even a single social media post by Ms. Grande can garner fees of several hundred thousand dollars, and her longer-term endorsement arrangements command fees in the millions of dollars.'' 1369

LOS ANGELES (AP) -- California fitness centers have filed a lawsuit alleging Gov. Gavin Newsom's measures aimed at curbing the spread of the coronavirus unfairly target the industry and are demanding they be allowed to reopen.Scott Street, a lawyer for the California Fitness Alliance, said Tuesday that the suit was filed in Los Angeles County Superior Court. It accuses state and Los Angeles County officials of requiring gyms to close without providing evidence that they contribute to virus outbreaks and at a time when staying healthy is critical to residents.State and county officials declined to comment on the suit. 632

LOS ANGELES, Calif. – Hallelujah! A third installment of the “Sister Act” franchise is officially in the works.Disney confirmed Thursday evening that “Sister Act 3” is in development, with Whoopi Goldberg set to reprise her role as Deloris Van Cartier.The entertainment company said the film will premiere on Disney+, but didn’t provide a target release date.Along with starring in the film, “The View” co-host will produce it as well, alongside Tyler Perry. The two have worked together before, most recently in 2018’s "Nobody’s Fool” with Tiffany Haddish.Goldberg has been trying to get “Sister Act 3” made for some time now. In 2018, she and Perry actually suggested working together on it with Haddish during an appearance on “Watch What Happens Live.”"The two of them in 'Sister Act,' that should happen. Let's make it happen," Perry said.More recently, Goldberg reiterated to James Corden on “The Late Late Show” how much she wanted to make the movie happen.“We’re working diligently to try and figure out every-, get the gang together and come back,” said Goldberg.The first "Sister Act" followed Whoopi's character, a lounge singer who was forced into the witness protection program and had to live with nuns in a convent. In the second film, her character taught music to a group of Catholic students whose run-down school was slated for closure. The premise of the third movie is unknown at this time. 1419

LOS ANGELES - A representative for Mel Gibson says the actor spent a week in a Los Angeles hospital in April after testing positive for COVID-19. The 64-year-old actor and director has completely recovered, is doing “great'' and has since tested negative “numerous times.” Gibson is the latest in a long string of high profile figures to go public with coronavirus diagnoses and recoveries including Tom Hanks, Rita Wilson, George Stephanopoulos and the singer Pink. The U.S. has more than 4 million known cases of the coronavirus and more than 140,000 deaths. 568

LONDON (AP) — AstraZeneca and Oxford University have acknowledged a manufacturing error that is raising questions about preliminary results of their COVID-19 vaccine.A statement Wednesday describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some participants didn’t receive as much vaccine as expected.In a surprise, the group of volunteers that got half a dose in the first of their two shots seemed to be better protected than the volunteers who got full doses. The low-dose group was smaller and younger, however, which could have skewed the results, experts say.In a statement obtained by CNN, Oxford elaborated further, saying that a “difference in the manufacturing process” had led to the error.The university said that it discussed the problem with regulators, agreed to complete the late stage trial with two groups, and the problem has since been corrected. 959